Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734774 | SCV000862943 | uncertain significance | not provided | 2018-08-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001127839 | SCV001287189 | benign | Renal cysts and diabetes syndrome | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV000734774 | SCV002248084 | uncertain significance | not provided | 2022-07-04 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 1 of the HNF1B gene. It does not directly change the encoded amino acid sequence of the HNF1B protein. This variant is present in population databases (rs200590728, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This variant has been observed in individual(s) with clinical features of diabetes (PMID: 27913849). ClinVar contains an entry for this variant (Variation ID: 598393). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Clinical Genomics, |
RCV002464304 | SCV002738641 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | HNF1B gene mutations are associated with early onset diabetes and pancreatic atrophy. It is also associated with multiple renal manifestations including renal cysts, Tubulointerstitial disease, glomerulocystic disease, renal hypoplasia, hypomagnesemia. However no sufficient evidence is found to ascertain the role of this particular variant rs200590728, yet. | |
Ce |
RCV000734774 | SCV004144496 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | HNF1B: BP4, BS2 |
Genome Diagnostics Laboratory, |
RCV000734774 | SCV002034160 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000734774 | SCV002035761 | likely benign | not provided | no assertion criteria provided | clinical testing |